Pharma group Krka posted record-high sales in 2023
Novo Mesto, 25 January - Pharma group Krka recorded 5% higher sales revenue last year compared to the year before, at EUR 1.81 billion, which is a new record, preliminary unaudited results show. Net profit was down 14% on 2022 due to foreign exchange losses, and amounted to an estimated EUR 311.2 million.
The rest of this news item is available to subscribers.
The news item consists of 2.366 characters (without spaces) or 491 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.